Marked differences in the apparent Mrs of the HN, NP and F proteins of simian virus 5 (SV5) and parainfluenza virus type 2 (PF-2) were revealed by SDS-PAGE. To examine the antigenic relationships between SV5, PF-2 and other paramyxoviruses, monoclonal antibodies (MAbs) specific to PF-2 were isolated. These antibodies had specificities for the HN, NP and P proteins and together with 54 MAbs to SV5 were tested for their ability to react with SV5, PF-2, PF-3, mumps and measles virus proteins. Most of these MAbs (55 out of 60) reacted with homologous virus only. However, five reacted with both SV5 and PF-2. These antibodies had reactivities to the NP, M and P proteins. Furthermore, one of the antibodies with reactivity to the P protein also reacted with mumps virus. Although none of the 21 MAbs with specificities for the HN protein of either SV5 or PF-2 cross-reacted with heterologous virus, some antigenic similarities between the HN protein of SV5 and PF-2 could be detected. This was demonstrated by raising a series of polyclonal antisera to purified preparations of SV5 or PF-2 HN proteins in BALB/c mice, and testing for their ability to neutralize both SV5 and PF-2 and also to immunoprecipitate the HN proteins of these viruses. Surprisingly, while low levels of cross-neutralizing antibody could be detected in some sera (e.g. neutralization of SV5 1:1600 and of PF-2 1:80), other sera with similar neutralization titres against homologous virus failed to neutralize heterologous virus. Furthermore, only a minority of the anti-HN antisera showed any immune-precipitating activity against the heterologous HN protein.
INTRODUCTION
Simian virus 5 (SV5) and parainfluenza virus type 2 (PF-2) are members of the parainfluenza virus genus (Kingsbury et al., 1978; Pringle, 1987) , a group which also includes viruses such as parainfluenza viruses (PF) types 1, 3 and 4, Sendal virus and Newcastle disease virus (NDV), viruses normally associated with respiratory diseases of birds and mammals. Mumps virus, which causes parotitis in man, is also a member of this group of viruses. These viruses have six main structural proteins, the haemagglutinin-neuraminidase (HN), fusion (F), matrix (M), nucleoprotein (NP), phosphoprotein (P) and large protein (L). Sequence and antigenic analyses have begun to reveal varying degrees of evolutionary relationship between these viruses. For example, using a large number of monoclonal antibodies (MAbs) to mumps virus, Sendai virus and PF-3, Orvell et al. (1986) showed that Sendai virus was antigenically related to mumps virus and PF-3, although they could not demonstrate any antigenic relationship between mumps virus and PF-3. None of their MAbs reacted with PF-2 or NDV. On the other hand, while sequence analysis of the F protein gene of mumps virus (Waxham et al., 1987) demonstrated a low level of amino acid sequence homology to both Sendai virus and PF-3 (25~o and 28~o respectively), a greater degree of homology was seen with the F proteins of SV5 (41 ~) and NDV (33 ~). Using polyvalent antisera Goswami & Russell (1982) showed that SV5 and PF-2 were antigenically related, as were PF-1 and PF-3. Ito et a/.(1987) also used polyvalent sera to examine the antigenic relationships of parainfluenza viruses and suggested that Sendai virus, human PF-I and PF-3 should be placed in one major antigenic group, and PF-2, PF-4, mumps virus and SV5 in a second. Furthermore, in a limited study with four MAbs raised to SV5, Goswami & RusseU (1983) showed that both of the MAbs to the NP protein of SV5 also reacted with PF-2 and that one of the two anti-HN MAbs also reacted with PF-2. Thus, although the degree of antigenic relatedness between SV5 and PF-2 is not known it has often been assumed that they are very closely related, and SV5 and PF-2 have even on occasion been classified in the same serotype (Pringle, 1987; Goswami & Russell, 1982) . We have previously isolated 54 MAbs to SV5 and used these to show that only minor antigenic variations exist between different simian, canine and human isolates of SV5 (Randall et al., 1987) . In contrast, we demonstrate in this paper that there are major antigenic differences between SV5 and PF-2 in that most (55 out of 60) MAbs to these viruses are specific for either SV5 or PF-2. Veto and BHK cells (Flow Laboratories) were grown as monolayers in 75 cm 2 tissue culture flasks or in rotating 80 oz Winchester bottles, in Dulbecco's modification of Eagle's tissue culture medium containing 10~ newborn calf serum. Two recent field isolates of PF-2 and prototype isolates of PF-2 and PF-3 were obtained from the Central Public Health Laboratories, Colindale, London, U.K. These viruses, together with the LN strain of SV5 (Goswami et al., 1984) , the Edmonston strain of measles and the Enders strain of mumps (kindly provided by Dr B. K. Rima, Queen's University of Belfast, U.K.), were grown and titrated under appropriate conditions in Vero cells using medium containing 2~o calf serum.
METHODS

Cells and viruses.
Immunization of mice, production and selection of antibody-secreting hybridomas and nomenclature for MAbs. The procedures used for the isolation of MAbs to PF-2 were the same as those described in detail for the production of MAbs to SV5 (Randall et al., 1987) . The nomenclature system for the PF-2 MAbs was similar to that used for the SV5 MAbs i.e. once the reactivity of the MAbs had been established, they were assigned capital letters corresponding to the virus protein recognized, followed by a trivial small letter as an identifying label for individual antibodies e.g. HNa. MAbs that reacted with the H N protein were tested for their ability to compete with the binding of other MAbs (for method see Randall et al., 1987) with reactivities to the same protein. If no competition between antibodies was noted these antibodies were placed in different groups which were given a number that was incorporated into the name of a particular antibody e.g. HN-la, HN-2a, HN-3a. The full name of the antibody was prefixed with PF-2 to denote that the antibody was isolated from mice immunized with PF-2, e.g. PF-2-HN-la. Thus, the six MAbs obtained were given the names PF-2-HN-la, -HN-2a, -HN-3a, -NPa, -NPb and -Pa.
Preparation of partially purified virus, radiolabelled antigen extracts, immune precipitation and SDS-PA GE. Vero or BHK cell monolayers in 75 cm 2 tissue culture flasks or in rotating 80 oz Winchester bottles were infected with 0-1 p.f.u, of SV5 or PF-2 per cell. After an adsorption period of 2 h at 37 °C, the inoculum was removed and replaced with tissue culture medium containing 2 ~ newborn calf serum. When the cells showed a 10 to 20~ c.p.e, they were radioactively labelled with L-[35S]methionine (500 Ci/mmol; Amersham) in tissue culture medium containing onetenth the normal concentration of unlabelled methionine (i.e. 1.5 mg/1). At the end of the labelling period the medium was harvested for virus purification and the cells were used to make soluble antigen extracts for the immune precipitation reactions, as described in detail elsewhere (Randall et al., 1987) . The proteins present in the immune precipitates and in the partially purified virus preparations were analysed by SDS-PAGE and autoradiography (Randall et al., 1987) .
Western blots. Polypeptides separated on polyacrylamide gels were transferred to sheets of 0-45 gm nitrocellulose by transverse electrophoresis using a semi-dry multi gel electroblotter (Ancas Aps from Dako, High Wycombe, U.K.). After transfer the filters, bearing samples of the electrophoretically separated polypeptides, were blocked with phosphate-buffered saline (PBS) containing 10~ milk powder (Marvel) overnight at 4 °C, incubated with antibody (e.g. 2 gl of ascitic fluid in 1 ml of PBS containing 0.1~ NP40) for 1 h at room temperature and then washed three times with PBS containing 0-1 ~ NP40. The filters were incubated at room temperature for 1 h with 12SI-labelled Protein A (Amersham; 0.5 gCi per ml of PBS), washed four times with PBS, dried and exposed to X-ray film with an intensifying screen at -70 °C.
Radioimmune assay to determine the reactivity of the different MAbs to various paramyxoviruses. Vero ceils, grown as monolayers in 96-weU microtitre plates, were infected with either SV5, PF-2, PF-3, mumps or measles viruses. When the cells showed an 80~ c.p.e. (24 to 36 h post-infection) the cells were fixed, with formol saline, permeabilized with NP40 and used as antigen to screen the reactivity of the MAbs as has been previously described in detail (Randall et al., 1987) .
Antisera. Polyvalent antisera to purified preparations of SV5 and PF-2 were raised in BALB/c mice using the immunization scheme described for the production of MAbs (Randall et al., 1987) . Monospecific polyclonal anti-SV5 HN or anti-PF-2 HN sera were prepared in BALB/c mice by two intraperitoneal injections of 5 to 10 gg of the HN protein, coupled to equimolar amounts of the MAbs SV5-HN-4a or PF-2-HN-1 a respectively (R. E. Randall, unpublished method Comparisons between PF-2 and SV5 2053 Immunofluorescence. Vero cells were grown as monolayers on 12-well Multispot microscope slides (C. A. Hendley, Loughton, U.K.) and infected with SV5 or PF-2 at 0.1 to 1.0 p.f.u./cell. At 24 h post-infection the monolayers were fixed, permeabilized and indirectly stained for immunofluorescence with specific MAbs as described by Randall & Dinwoodie (1986) .
Neutralization test. Twofold dilutions of mouse sera or MAbs (as ascitic fluids) (100 p.1) in tissue culture medium containing 2~ calf serum were incubated at 37 °C for 2 h with 100 ~tl of PF-2 or SV5 (1 x 103 p.f.u./ml). The antibody-virus mixtures were then used to infect Vero cells growing as monolayers in 96-well microtitre plates. After a 2 to 4 h adsorption period the virus-antibody inoculum was replaced with tissue culture medium containing 2 ~ calf serum and the cells were reincubated at 37 °C for a further 24 to 36 h. The cells were then fixed, permeabilized and the presence of virus antigens was detected using a pool of MAbs in a radioimmune assay performed as described above.
RESULTS
Virion proteins of SV5 and PF-2 and the production of MAbs to PF-2
The apparent MrS of SV5 and PF-2 virion proteins were compared by SDS-PAGE of partially purified virus preparations. Such an analysis revealed marked differences in the Mr of the virion polypeptides and in particular in the HN, NP and F proteins. In addition, the L protein of PF-2 had a higher apparent Mr than the L proteins of SV5. Much less variation was noted in the mobilities in SDS-PAGE of the P and M proteins ( Fig. 1) .
To characterize further the antigenic relationships between SV5, PF-2 and other paramyxoviruses we prepared a series of MAbs to SV5 and PF-2, the properties of the 54 MAbs to SV5 having been reported elsewhere (Randall et al., 1987) . MAbs to PF-2 were produced by immunizing BALB/c mice with purified preparations of PF-2. Six MAbs to PF-2 were isolated, three with specificities for the HN protein, two with specificities for the NP protein and one for the P protein (Fig. 2) . Neutralization tests showed that the three anti-HN MAbs neutralized virus infectivity, and competition radioimmune assays showed that these antibodies recognized different antigenic sites on the HN protein (data not shown). Five of the six MAbs reacted with two recent field isolates of PF-2, but MAb HN-1 a was specific for the prototype strain that was used to immunize the mice in the production of MAbs (Fig. 3) .
Antigenic comparisons between SV5, PF-2 and other paramyxoviruses as revealed by MAbs
The 54 MAbs to SV5 and six to PF-2 were tested for their ability to react with both SV5 and PF-2 as well as with PF-3, mumps and measles viruses. The main method used to screen the reactivity of the MAbs was a radioimmune assay in which the MAbs were reacted with virusinfected cells that had been grown in 96-well microtitre plates (e.g. Fig. 4 ). The vast majority of MAbs reacted with homologous virus only. Thus out of 60 MAbs tested only five reacted with both SV5 and PF-2 and one of these (SV5-Pe) also reacted with mumps virus. More specifically the numbers of MAbs that cross-reacted with SV5 and PF-2 were none out of 21 to the HN proteins, two out of 22 to the M protein, two of five to the NP protein and one out of 12 to the P protein. The MAb previously isolated that was specific to the SV5 F protein did not react with PF-2 and none of the MAbs reacted with PF-3 or measles viruses. The ability of MAbs to crossreact with heterologous virus was confirmed either by immune precipitation (e.g. Fig. 2) or by Western blot analysis where applicable (e.g. Fig. 5 ).
Further studies on the antigenicity of the HN proteins of SV5 and PF-2
The immunization schedules used for the production of MAbs and the subsequent screening tests employed to identify hybridomas secreting specific antibodies may result in a biased selection of highly specific high affinity binding MAbs. Consequently the MAbs we selected may not be a true reflection of the antibodies produced during a polyclonal response in which a broad spectrum of high and low affinity antibodies will be produced. Therefore, to compare further the antigenic similarities and differences between the HN protein of SV5 and PF-2, 19 polyclonal sera were raised in BALB/c mice against purified preparations of the HN protein of SV5. While all these antisera efficiently neutralized SV5 (Table 1) and immune-precipitated the HN protein of SV5 (Fig. 6 ) they showed only weak or no reactivity in these tests against PF-2 ( Table 1, Fig. 6 ). Interestingly, however, the i m m u n e response to the purified H N protein of SV5 appeared to differ from mouse to mouse. Thus, it can be seen from Table 1 that although some sera had the same level of neutralizing activity against SV5 they m a y or m a y not have had neutralizing activity against PF-2, e.g. compare sera 5 and 13. However, it should be stressed that the neutralization titre of these sera against SV5 was always at least 10-fold higher against SV5 than against PF-2. Furthermore although all these sera efficiently immune-precipitated the 1 and 3) . The polypeptides present in the immune precipitates were separated by electrophoresis through a 10~o SDS-polyacrylamide slab gel. H N p r o t e i n of SV5 only a few s h o w e d a n y i m m u n e -p r e c i p i t a t i n g activity a g a i n s t t h e H N p r o t e i n of PF-2 (e.g. Fig. 6 ). T h r e e polyclonal sera were also raised a g a i n s t the H N p r o t e i n of P F -2 ; these sera h a d n e u t r a l i z a t i o n titres of b e t w e e n 1/800 a n d 1/3200 a g a i n s t PF-2 but failed to neutralize SV5 at a 1/20 dilution (Table 1) . 
DISCUSSION
MAbs were isolated that had reactivities to the HN, NP and P proteins of PF-2. The three MAbs that reacted with the HN protein of PF-2 defined different epitopes involved in virus neutralization. Two of these epitopes were common to three different isolates, while one was specific for the PF-2 isolate against which the MAbs were raised. The MAbs to PF-2 together with a much larger number of MAbs raised against SV5 (Randall et al., 1987) were used to examine the antigenic relationships between SV5, PF-2 and other paramyxoviruses. These studies showed that while SV5 and PF-2 were more related to each other than to mumps virus or PF-3, there were major antigenic differences between the former two viruses in that the majority of the MAbs (55 out of 60) were specific to the virus against which they were raised. However, MAbs were identified with specificities to the NP, P and M proteins that reacted with both SV5 and PF-2. Furthermore, polyclonal anti-HN sera (see below) revealed a low level of antigenic similarity between the HN proteins of SV5 and PF-2. While small variations in the Mr of the virion proteins of different PF-2 isolates were noted (e.g. the HN protein, Fig. 3 ) the overall pattern was very similar and clearly very distinct from that of SV5 (Randall et al., 1987) . Thus, in general agreement with other published data on the polypeptides of PF-2 (Goswami & Russell, 1982; Cowley & Barry, 1983) , SDS-PAGE analysis showed marked differences in the apparent Mr values of the L, HN, NP and F proteins of SV5 and PF-2, the P and M proteins having similar electrophoretic mobilities. We had previously shown that there was little variation between different human, dog or monkey isolates of SV5 either in terms of the apparent Mr of the virion proteins or in terms of their ability to react with the pool of SV5 MAbs used in this The autoradiogram shown in (a) represents an SDS-PAGE gel exposed for 2 weeks; that shown in (b) was exposed for 10 weeks.
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study (Randall et al., 1987) . The results presented in this paper therefore provide evidence that SV5 and PF-2 are distinct species of viruses and are not as closely related antigenically as has been thought (e.g. Goswami & Russell, 1982) . However, sequence analysis is required to determine the exact level of evolutionary relatedness of these two viruses. The SV5 and PF-2 MAbs were also tested for their ability to react with PF-3, mumps and measles viruses. Only one of the antibodies reacted with mumps virus and none reacted with PF-3 or measles virus. The antibody that reacted with mumps virus was specific for the P protein. This M A b (SV5-Pe) also reacted with both SV5 and PF-2, and thus must define an important antigenic determinant on the P protein which has been conserved during evolution. M A b SVS-Pe also appeared to react with the internal non-structural proteins V of SV5 (Paterson et al., 1984) and mumps virus (Herder & Compans, 1982) that are read from separate initiation sites on the same gene as the P protein (Fig. 5) . A longer exposure of the Western blot shown in Fig. 5 also showed that there were a number of polypeptides present in PF-2-infected cells with similar Mrs to protein V of SV5 which reacted with this M A b (data not shown). However, it was not clear whether these were similar to the non-structural proteins of SV5 and mumps virus or were breakdown products of the PF-2 P protein.
Sero-epidemiological studies have shown that 20 to 50 ~ of human sera have antibodies that react with purified preparations of the H N protein of SV5 in a radioimmune assay (R. E. Randall, unpublished observations Comparisons between PF-2 and SV5 2059 neutralize SV5 infectivity at serum dilution titres of between 1/20 and 1/160 (Hsiung, 1972; Goswami et al., 1984) . The interpretation of such data in terms of the epidemiology of SV5 infections of humans has been complicated by the antigenic relationship between SV5 and PF-2. However, the data present in this paper show that while there is some antigenic identity between the HN proteins of SV5 and PF-2 the major antigenic determinants are specific to each virus. Thus none of the 21 MAbs isolated to the HN protein of either SV5 or PF-2 cross-react with heterologous virus. Furthermore, polyclonal mouse sera to the HN proteins of SV5 and PF-2 are dominated by antibodies that are specific for the immunizing antigen. Although a low level of cross-reactivity was present in some sera, the level of neutralization against the heterologous virus was always at least 10-fold lower than against the homologous virus. Interestingly, however, these data did show that there was variation in the immune response of individual mice with the same genetic background. Thus, some mice had cross-reacting antibody, whereas other mice with similar levels of neutralizing activity against the homologous virus had no detectable cross-reacting antibody. The variation in the immune response, with respect to the level of cross-reacting PF-2/SV5 antibody induced, in the outbred human population is likely to be even greater. This may be further complicated by the fact that any individual may be persistently or sequentially infected with different paramyxoviruses with varying degrees of antigenic relatedness. Furthermore, cross-neutralizing SV5/PF-2 antibody in human sera may occur through antibody directed at the F glycoproteins of these viruses. However, while two polyclonal mouse sera to the F protein of SV5 neutralized SV5 at dilutions of 1/80 and 1/160, they failed to show any neutralizing activity against PF-2 (data not shown). Although the level of neutralizing activity in human sera is usually higher against PF-2 than against SV5 some human sera have similar titres of neutralizing activity against the two viruses (R. E. Randall, unpublished observations) and on the basis of the data presented in this paper it is unlikely that this could be due to cross-reacting antibody. However, accurate estimations of the exact incidence of SV5 infection within the human population will be dependent upon the use of sensitive and specific competition assays using MAbs of defined specificity (e.g. Goswami et al., 1984) .
